Surgeon General David Satcher announced a year-long effort to develop a national action plan for reducing the prevalence of obesity in the United States. Satcher said the process would be inclusive and collaborative, and would include open public comment periods, listening sessions, federal and non-federal dialogue, interactive workshops, and the formation of working groups to implement strategies.
Surgeon General David Satcher announced a year-long effort to develop a national action plan for reducing the prevalence of obesity in the United States. Satcher said the process would be inclusive and collaborative, and would include open public comment periods, listening sessions, federal and non-federal dialogue, interactive workshops, and the formation of working groups to implement strategies.
"The prevalence of overweight and obesity has nearly doubled among children and adolescents since 1980," Satcher told public health and industry leaders attending an international nutrition conference. "It is also increasing in both genders and among all population groups of adults. We want to establish strategies and set priorities so that we can successfully implement obesity prevention efforts that focus on the family and community, schools, work sites, the healthcare delivery system and the media."
Several follow-up events will continue efforts to develop a national action plan. An invitational, interactive workshop to further develop strategies and stimulate collaboration is in the planning stages. A meeting of federal agencies will begin dialogue to develop a coordinated federal approach. Further opportunity for public input in development of the plan is envisioned during 2001.
Obesity substantially raises the risk of illness from high blood pressure, high cholesterol, type 2 diabetes, heart disease and stroke, gallbladder disease, arthritis, sleep disturbances and breathing problems, and certain types of cancer. On average, higher body weights are associated with higher death rates. The number of overweight children, adolescents and adults has risen over the past four decades. Total costs (medical costs and lost productivity) attributable to obesity alone amounted to an estimated $99 billion in 1995. PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.